Hyperimmune Bovine Colostrum for Blocking Gluten Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for gluten-related disorders, such as celiac disease and non-celiac gluten sensitivity, are inadequate, particularly in managing symptoms and preventing absorption of gluten due to the challenges of maintaining a strict gluten-free diet and the lack of effective adjunct therapies.
Innovation Solution
Development of a vaccine in cows to stimulate the production of immunoglobulins that specifically bind to gluten peptides, followed by the use of hyperimmune bovine colostrum containing these antibodies to inhibit gluten absorption in the human gastrointestinal tract.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a strict gluten-free diet is maintained, then absorption of gluten is prevented, but quality of life and ease of operation deteriorate due to dietary restrictions and social limitations
Solution Approach 1:
The patent introduces an intermediary substance (hyperimmune bovine colostrum containing anti-gliadin antibodies) that acts as a mediator between gluten and the human intestinal tract. This colostrum binds to gluten peptides in the gastrointestinal lumen, preventing their absorption without requiring the patient to maintain a strict gluten-free diet. The intermediary effectively neutralizes the harmful substance while allowing normal dietary habits to continue.
2Object-affected harmful factors
If gluten is completely eliminated from the diet, then symptoms of gluten-related disorders are alleviated, but productivity and convenience deteriorate due to limited food choices and preparation complexity
Solution Approach 1:
The patent converts the harmful effect of gluten into a beneficial one by using hyperimmune bovine colostrum that specifically binds to gluten peptides. The colostrum transforms the toxic gliadin peptides into harmless complexes that can be safely excreted, thereby converting the harmful presence of gluten in the diet into a beneficial therapeutic effect that allows patients to consume gluten-containing foods without adverse reactions.
3Reliability
If adjunct therapies are developed to treat gluten-related disorders, then treatment effectiveness is improved, but device complexity and manufacturing difficulty increase
Solution Approach 1:
The patent employs a self-service mechanism where hyperimmune bovine colostrum naturally contains high concentrations of anti-gliadin antibodies that automatically bind to gluten peptides in the gastrointestinal tract. The colostrum's immunoglobulins self-assemble and self-neutralize the toxic peptides without requiring complex delivery systems, sophisticated manufacturing processes, or complex administration protocols. This simplifies the adjunct therapy while maintaining high treatment effectiveness.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hyperimmune bovine colostrum effectively reduces the absorption of gluten peptides, providing an adjunct therapy that complements a gluten-free diet and alleviates symptoms of gluten-related disorders by enhancing immune response and reducing toxic effects.
Implementation Method 1
the colostrum comprises an immunoglobulin that specifically binds to gluten or partially digested gluten
Data Source
AI summary
Provided are compositions and methods for alleviating symptoms or treating gluten-related diseases. In some embodiments, the compositions include colostrum from cows that are immunized with gluten or partially digested gluten.